ONCOLYTICS BIOTECH® REPORTS STRONG DURABILITY AND SURVIVAL DATA IN ANAL CANCER, POSITIONING PELAREOREP AS POTENTIAL BACKBONE IMMUNOTHERAPY ACROSS HPV-DRIVEN CANCERS

Reuters · 2d ago

Please log in to view news